BNTX now $88.80 (RSI 33 — still oversold). CRSP $48.87 (RSI 39, -13.9% 7D). MRNA $54.51 (RSI 60). LLY $976.59 (RSI 41, below $1,000). LEGN $19.42 (RSI 54). BEAM $25.74 (RSI 43). ALNY $312.14 (RSI 36). BIIB $186.62 (RSI 49). GILD $146.60 (RSI 52). NTLA $12.90 (RSI 49). VRTX $485.55 (RSI 54, golden cross). TMO $476.70 (RSI 28 — oversold). DHR $187.98 (RSI 24 — extreme oversold).
Quick Snapshot
| Signal |
Reading |
| Overall |
🔴 BROAD OVERSOLD — BNTX RSI 33 still distressed at $88.80. DHR RSI 24 and TMO RSI 28 — life sciences tools crashing. LLY broke below $1,000. CRSP -13.9% 7D adding to pain. MRNA RSI 60 and VRTX RSI 54 are the standouts. |
| Key insight |
DHR $187.98 RSI 24 and TMO $476.70 RSI 28 — life sciences tools sector in full collapse, joining BNTX as extreme oversold. LLY $976.59 RSI 41 lost $1,000 support. MRNA $54.51 RSI 60 strong-up trend is the one bright spot in the theme. VRTX $485.55 RSI 54 golden cross — only -3.9% from 52wk high. |
Action Matrix
| Action |
Stocks |
Why |
| 🔍 RESEARCH |
DHR |
$187.98, RSI 24, -12.5% 30D — life sciences tools at capitulation |
| 🔍 RESEARCH |
TMO |
$476.70, RSI 28, -6.5% 30D — Thermo Fisher in oversold zone |
| ✅ BUY |
BNTX |
$88.80, RSI 33, -16.0% 30D — mRNA pioneer, still oversold |
| 📈 ACCUMULATE |
LLY |
$976.59, RSI 41, below $1,000 — GLP-1 leader with support test |
| 🔒 HOLD |
MRNA |
$54.51, RSI 60, +35.9% 30D — strong recovery, let it run |
| 🔒 HOLD |
VRTX |
$485.55, RSI 54, golden cross — only -3.9% from 52wk high |
| 🔒 HOLD |
BIIB |
$186.62, RSI 49 — stable |
| 🔒 HOLD |
GILD |
$146.60, RSI 52 — stable |
| 🔒 HOLD |
LEGN |
$19.42, RSI 54 — continuing recovery |
| 🔒 HOLD |
NTLA |
$12.90, RSI 49 — above SMA20 (slightly) |
| 🔍 WATCH |
ALNY |
$312.14, RSI 36, death cross — oversold zone |
| 🔍 WATCH |
CRSP |
$48.87, RSI 39 — -13.9% 7D, death cross |
| 🔍 WATCH |
BEAM |
$25.74, RSI 43 — below SMA20 |
Data (Validated 2026-03-12)
| Stock |
Price |
7D |
30D |
52wkHi |
RSI |
SMA20 |
vs SMA |
Status |
Action |
| DHR |
$187.98 |
-3.9% |
-12.5% |
-19.6% |
24 |
$205.11 |
-8.3% |
🔴 Extreme oversold |
🔍 Research |
| TMO |
$476.70 |
-3.3% |
-6.5% |
-26.0% |
28 |
$508.79 |
-6.3% |
🔴 Oversold |
🔍 Research |
| BNTX |
$88.80 |
-10.7% |
-16.0% |
-32.4% |
33 |
$103.90 |
-14.5% |
🔴 Oversold |
✅ Buy |
| ALNY |
$312.14 |
-0.6% |
+1.2% |
-35.0% |
36 |
$325.41 |
-4.1% |
🟡 Oversold zone, death cross |
🔍 Watch |
| CRSP |
$48.87 |
-13.9% |
-0.1% |
-37.7% |
39 |
$55.38 |
-11.8% |
🟡 Dropping, death cross |
🔍 Watch |
| LLY |
$976.59 |
+1.5% |
-5.8% |
-13.9% |
41 |
$1,017.92 |
-4.1% |
🟡 Below SMA, lost $1K |
📈 Accumulate |
| BEAM |
$25.74 |
-2.3% |
-4.4% |
-28.4% |
43 |
$27.70 |
-7.1% |
🟡 Weak, below SMA |
🔍 Watch |
| BIIB |
$186.62 |
+0.6% |
-4.5% |
-6.0% |
49 |
$190.83 |
-2.2% |
🟢 Stable |
🔒 Hold |
| NTLA |
$12.90 |
-5.4% |
+11.0% |
-54.0% |
49 |
$13.24 |
-2.6% |
🟢 Near SMA |
🔒 Hold |
| GILD |
$146.60 |
+0.7% |
-3.4% |
-6.8% |
52 |
$148.88 |
-1.5% |
🟢 Stable, strong-up |
🔒 Hold |
| LEGN |
$19.42 |
+15.6% |
+7.5% |
-56.8% |
54 |
$18.75 |
+3.5% |
🟢 Recovering |
🔒 Hold |
| VRTX |
$485.55 |
+5.2% |
+4.4% |
-4.0% |
54 |
$478.62 |
+1.4% |
🟢 Golden cross, near high |
🔒 Hold |
| MRNA |
$54.51 |
-2.0% |
+35.9% |
-8.5% |
60 |
$50.90 |
+7.1% |
🟢 Strong recovery |
🔒 Hold |
Key Changes vs 03/11
| Stock |
03/11 Price |
03/12 Price |
Move |
Note |
| BNTX |
$83.89 |
$88.80 |
+5.9% |
Small bounce — but RSI 33 still in oversold zone |
| CRSP |
$49.94 |
$48.87 |
-2.1% |
Continued decline — RSI 39, death cross |
| LLY |
$999.10 |
$976.59 |
-2.3% |
Broke below $1,000 — RSI 41, losing support |
| MRNA |
$56.08 |
$54.51 |
-2.8% |
Small pullback — RSI 60 still strong |
| LEGN |
$19.56 |
$19.42 |
-0.7% |
Flat — RSI 54 recovery intact |
| VRTX |
(new) |
$485.55 |
NEW |
Added — RSI 54, golden cross, -3.9% from 52wk high |
| DHR |
(new) |
$187.98 |
NEW |
Added — RSI 24, life sciences tools collapse |
| TMO |
(new) |
$476.70 |
NEW |
Added — RSI 28, Thermo Fisher capitulating |
Key Discoveries
| Discovery |
Implication |
| DHR RSI 24, TMO RSI 28 — life sciences tools sector collapsing |
Two megacap healthcare tools companies in extreme oversold — systemic pressure |
| LLY broke below $1,000 support |
GLP-1 leader losing key psychological level — RSI 41, accumulate zone |
| VRTX golden cross, -3.9% from 52wk high |
The strongest biotech on a technical basis — defensive quality |
| BNTX bounced $84→$89 but RSI only 33 |
Not out of the woods yet — still in buy zone |
Mistakes (Don't Repeat)
| Mistake |
Lesson |
| Missing DHR/TMO in prior biotech scans |
Life sciences tools (DHR, TMO) belong in biotech theme — they're being hit harder than pharma |
Open Questions
- DHR RSI 24 + TMO RSI 28 — are life sciences tools at capitulation or more downside?
- LLY below $1,000 — does $950 hold or does this become a longer correction?
- BNTX $88.80 RSI 33 — is the $80 level the real floor?
- MRNA RSI 60 — approaching overbought after +35.9% 30D?
- VRTX near 52wk high — breakout candidate in a weak sector?